Publications Archives
Hepatitis A
Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review
Hepatitis A (HA) is a vaccine‐preventable liver disease caused by a single‐stranded ribonucleic acid virus (HAV). Infection may result in severe outcomes, especially at increasing ages and in older adults. HAV is resistant to low pH as well as heat and freezing temperatures and is mainly...
Hepatitis A
The Burden of Hepatitis A Outbreaks in the United States: Health Outcomes, Economic Costs, and Management Strategies
Hepatitis A (HepA) vaccines are recommended for United States (US) adults at risk of HepA. Ongoing US HepA outbreaks since 2016 have primarily spread person-to-person, especially among at-risk groups. We investigated the health outcomes, economic burden, and outbreak management considerations associated...
Hepatitis A
Severity of the clinical presentation of hepatitis A in five European countries from 1995 to 2014.
We analysed Hepatitis A (HepA) notifications and hospitalisations in Italy, Netherlands, Norway, Spain and Sweden for available periods between 1995 and 2014 to investigate whether decreasing HepA incidence is associated with increasing age at infection and worsening HepA presentation, and to identify...
Hepatitis A
Widespread Hepatitis A Outbreaks Associated with Person-to-Person Transmission - United States, 2016-2020.
Hepatitis A is a vaccine-preventable disease typically acquired through fecal-oral transmission. Hepatitis A virus (HAV) infection rates in the United States declined approximately 97% during 1995-2015 after the introduction and widespread pediatric use of hepatitis A vaccines (1). Since 2016, hepatitis...
